Light Mode
$22.99 ↓ -0.12 (-0.52%) Trading Down from the previous close of $23.11
+5.57 (+31.76%) / 6M
Momentum, market sentiment, and recent alerts
QURE reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -61.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.